Skip to main content
PA

PaxMedica

Tarrytown, United States
Last funding
$7.0M
Post-IPO EquityNov 2023

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

Backed byThe Lind PartnersLincoln Park Capital Fund

About PaxMedica

How much funding has PaxMedica raised?

PaxMedica has raised $7.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2023.

Who are PaxMedica's investors?

PaxMedica's investors include The Lind Partners, Lincoln Park Capital Fund.

Where is PaxMedica headquartered?

PaxMedica is headquartered in Tarrytown, United States.

What does PaxMedica do?

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

What stage is PaxMedica at?

PaxMedica is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"PaxMedica — Funding & Investors." VCBacked, November 20, 2023, https://www.vcbacked.co/company/paxmedica. Accessed November 12, 2026.
APA
VCBacked. (2023). PaxMedica — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/paxmedica
Wikipedia (cite web)
{{cite web |title=PaxMedica — Funding & Investors |url=https://www.vcbacked.co/company/paxmedica |website=VCBacked |access-date=November 12, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at PaxMedica? Request a listing update

Founder contacts
m***@paxmedica.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →